March 19, 2019 / 1:34 AM / 3 months ago

BRIEF-FDA Approves Genentech's Tecentriq In Combination With Chemotherapy For Initial Treatment Of Adults With Extensive-Stage Small Cell Lung Cancer

March 18 (Reuters) - Roche Holding AG:

* FDA APPROVES GENENTECH’S TECENTRIQ IN COMBINATION WITH CHEMOTHERAPY FOR THE INITIAL TREATMENT OF ADULTS WITH EXTENSIVE-STAGE SMALL CELL LUNG CANCER Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below